Company Profile

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE2196.8561 (+2.86 % )
PREV CLOSE (Rs.) 2135.85
OPEN PRICE (Rs.) 2151.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 111547
TODAY'S LOW / HIGH (Rs.)2087.50 2275.00
52 WK LOW / HIGH (Rs.)1058.5 2455.55
NSE2166.75 30.05 (+1.41 % )
PREV CLOSE(Rs.) 2136.70
OPEN PRICE (Rs.) 2139.80
BID PRICE (QTY) 2166.75 (67294 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 8560495
TODAY'S LOW / HIGH(Rs.) 2086.50 2280.00
52 WK LOW / HIGH (Rs.)1058.1 2460

Quaterly Results

(Rs in Million)
";
Particulars Sep 2020 Jun 2020 Mar 2020 Dec 2019
Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 13611 15344 10737.6 12128.6
Total Expenditure 10009.1 9460.8 9052.8 9392
PBIDT (Excl OI) 3601.9 5883.2 1684.8 2736.6
Other Income 154.5 120.9 137.3 181.3
Operating Profit 3756.4 6004.1 1822.1 2917.9
Interest 23.1 27.4 36.7 40.1
Exceptional Items NA NA NA NA
PBDT 3733.3 5976.7 1785.4 2877.8
Depreciation 521.2 510.3 639.4 508.3
Profit Before Tax 3212.1 5466.4 1146 2369.5
Tax 525.9 998.9 292 368.9
Provisions and contingencies NA NA NA NA
Profit After Tax 2686.2 4467.5 853.99 2000.6
Extraordinary Items NA NA NA NA
Prior Period Expenses NA NA NA NA
Other Adjustments NA NA NA NA
Net Profit 2686.2 4467.5 853.99 2000.6
Minority Interest 3.7 4.5 29.6 0.7
Shares of Associates -19.2 -10.7 -23.3 -25.2
Other related items
Misc. Expenses Written off NA NA NA NA
Consolidated Net Profit 2670.7 4461.3 860.1 1976.1
Equity Capital 253.7 252.7 252.7 252.7
Face Value (IN RS) 2 2 2 2
Reserves NA NA NA NA
Calculated EPS 21.05 35.30 6.80 15.63
Calculated EPS (Annualised) 84.21 141.23 27.22 62.55
No of Public Share Holdings 68135873 68135873 68135873 68135873
% of Public Share Holdings 53.93 53.93 53.93 53.93
  NA NA NA NA
PBIDTM% (Excl OI) 26.46 38.34 15.69 22.56
PBIDTM% 27.59 39.12 16.96 24.05
PBDTM% 27.42 38.95 16.62 23.72
PBTM% 23.59 35.62 10.67 19.53
PATM% 19.73 29.11 7.95 16.49
 Notes Notes Notes Notes